CBD Rejected as a Dietary Supplement by the FDA
The US Food and Drug Administration (FDA) recently elected not to regulate cannabidiol (CBD) products as a dietary supplement.
CBD Products and Impact on Drug Test Results
The Agricultural Improvement Act of 2018 changed the working definition of marijuana under the Controlled Substances Act, declaring that hemp-derived products containing no more than 0.3% tetrahydrocannabinol, or THC, are not considered controlled substances. This new designation led to a flurry of unregulated CBD products hitting markets nationwide, which in turn affects drug testing that could impact your business. Because …
Oklahoma Medical Marijuana “Unity Bill” Takes Effect August 29, 2019
The Oklahoma Medical Marijuana Patient Protection Act, commonly referred to as the medical marijuana “Unity Bill,” took effect August 29, 2019.
CBD Revealed: The Truth Behind CBD and Drug Testing
As cannabidiol, referred to as CBD, continues to gain popularity for medicinal purposes, it’s essential that employers are educated on the drug, and the impact employee use may have on their drug and alcohol program.
Oklahoma Medical Marijuana and Patient Protect Act Provides Clarity to Oklahoma Employers
On March 14, Oklahoma Gov. Kevin Still signed into law the Oklahoma Medical Marijuana and Patient Protect Act. Better known as the medical marijuana “Unity Bill,” the law adds regulatory clarity to the state’s medical marijuana law, specifically as it relates to Oklahoma employers.